Now showing items 1-6 of 6
Clinicopathologic Significance of Histologic Grade, Pgp, and P53 Expression in Canine Lymphoma
(Amer Animal Hospital Assoc, 2013-05-01)
To characterize the expression of P-glycoprotein (Pgp) and p53 in different histologic grades of canine multicentric lymphosarcoma (LSA), 31 cases of LSA without prior treatment were studied. The expression levels of the ...
Efficacy of temozolomide or dacarbazine in combination with an anthracycline for rescue chemotherapy in dogs with lymphoma
(Amer Veterinary Medical Assoc, 2007-08-15)
Objective: To compare results of treatment with temozolomide or dacarbazine, in combination with an anthracycline, in dogs with relapsed or refractory lymphoma. Design: Nonrandomized, controlled clinical trial. Animals: ...
Measurement of serum carboxyterminal cross-linked telopeptide of type I collagen concentration in dogs with osteosarcoma
(Amer Veterinary Medical Assoc, 2008-11-01)
Objective—To evaluate the usefulness of carboxyterminal cross-linked telopeptide of type I collagen (ICTP) concentrations for screening dogs for the presence of osteosarcoma. Sample Population—32 client-owned dogs with ...
Treatment-related toxicities in tumor-bearing cats treated with temozolomide alone or in combination with doxorubicin: a pilot assessment
(Sage Publications Ltd, 2012-08-01)
A retrospective study assessing treatment-related toxicities in tumor-bearing cats treated with temozolomide (TMZ) alone or in combination with doxorubicin was conducted. TMZ was administered orally once a day for 5 days ...
Evaluation and comparison of outcomes in dogs with periarticular and nonperiarticular histiocytic sarcoma
(Amer Veterinary Medical Assoc, 2011-07-01)
Objective—To evaluate and compare the outcomes of dogs with periarticular histiocytic sarcoma (PAHS) and histiocytic sarcoma of other anatomic locations (non-PAHS) and identify factors associated with outcome for dogs with ...
Tolerability of Gemcitabine and Carboplatin Doublet Therapy in Cats with Carcinomas
(Wiley-Blackwell Publishing, Inc, 2009-05-01)
Background: This study was performed to determine the toxicity of gemcitabine-carboplatin doublet therapy in cats with carcinomas. Hypothesis: Gemcitabine and carboplatin are safe in tumor-bearing cats. Animals: ...